Browse by Uncontrolled Keywords

Export as [feed] Atom [feed] RSS
Group by: Year | Authors/Creators | Item Type | Full Text
Jump to: 2011 | 2007 | 2006 | 2005 | 2004 | 2003
Number of items: 9.

2011

Bujkiewicz, S; Jones, HE; Lai, MC; Cooper, NJ; Hawkins, N; Squires, H; Abrams, KR; Spiegelhalter, DJ; Sutton, AJ; (2011) Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value in health, 14 (5). pp. 768-76. ISSN 1098-3015 DOI: https://doi.org/10.1016/j.jval.2010.12.002
[img]

2007

Bravo Vergel, Y; Hawkins, NS; Claxton, K; Asseburg, C; Palmer, S; Woolacott, N; Bruce, IN; Sculpher, MJ; (2007) The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford, England), 46. pp. 1729-35. ISSN 1462-0324 DOI: https://doi.org/10.1093/rheumatology/kem221 Full text not available from this repository.

Weldon, SM; Mullen, AC; Loscher, CE; Hurley, LA; Roche, HM; (2007) Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. The Journal of nutritional biochemistry, 18 (4). pp. 250-8. ISSN 0955-2863 DOI: https://doi.org/10.1016/j.jnutbio.2006.04.003 Full text not available from this repository.

2006

Woolacott, N; Bravo Vergel, Y; Hawkins, N; Kainth, A; Khadjesari, Z; Misso, K; Light, K; Asseburg, C; Palmer, S; Claxton, K; +3 more... Bruce, I; Sculpher, M; Riemsma, R; (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 10. iii-iv, xiii-xvi, 1-239. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/2534859
[img]

2005

Moore, TA; Lau, HY; Cogen, AL; Standiford, TJ; (2005) Defective innate antibacterial host responses during murine Klebsiella pneumoniae bacteremia: tumor necrosis factor (TNF) receptor 1 deficiency versus therapy with anti-TNF-alpha. Clinical infectious diseases, 41 Sup. S213-7. ISSN 1058-4838 DOI: https://doi.org/10.1086/430126 Full text not available from this repository.

Siddiqui, AA; Brouwer, AE; Wuthiekanun, V; Jaffar, S; Shattock, R; Irving, D; Sheldon, J; Chierakul, W; Peacock, S; Day, N; +2 more... White, NJ; Harrison, TS; (2005) IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. Journal of immunology (Baltimore, Md, 174 (3). pp. 1746-1750. ISSN 0022-1767 DOI: https://doi.org/10.4049/jimmunol.174.3.1746 Full text not available from this repository.

2004

Engwerda, CR; Ato, M; Stager, S; Alexander, CE; Stanley, AC; Kaye, PM; (2004) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of leishmania donovani infection. The American journal of pathology, 165 (6). pp. 2123-33. ISSN 0002-9440 DOI: https://doi.org/10.1016/S0002-9440(10)63262-2 Full text not available from this repository.

2003

Moore, TA; Lau, HY; Cogen, AL; Monteleon, CL; Standiford, TJ; (2003) Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury. Shock (Augusta, Ga), 20 (4). pp. 309-15. ISSN 1073-2322 DOI: https://doi.org/10.1097/01.shk.0000087203.34916.45 Full text not available from this repository.

Moore, TA; Perry, ML; Getsoian, AG; Monteleon, CL; Cogen, AL; Standiford, TJ; (2003) Increased mortality and dysregulated cytokine production in tumor necrosis factor receptor 1-deficient mice following systemic Klebsiella pneumoniae infection. Infection and immunity, 71 (9). pp. 4891-900. ISSN 0019-9567 DOI: https://doi.org/10.1128/IAI.71.9.4891-4900.2003 Full text not available from this repository.

This list was generated on Sat Jul 20 20:18:42 2019 BST.